Source:http://linkedlifedata.com/resource/pubmed/id/12917457
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
Pt 9
|
pubmed:dateCreated |
2003-8-14
|
pubmed:abstractText |
Mouse monoclonal antibodies (mAbs) were employed to select neutralization escape mutants of equine rhinitis A virus (ERAV). Amino acid changes in the ERAV mutants resulting in resistance to neutralization were identified in capsid protein VP1 at Lys-114, Pro-240 and Thr-241. Although the changes were located in different parts of the polypeptide chain, these mutants exhibited cross-resistance against all four mAbs employed, indicating that these residues contribute to a single immunogenic site. To explain this result, we constructed a model of the three-dimensional structure of the ERAV capsid based on comparison with the closely related foot-and-mouth disease virus (FMDV O(1)). According to this model, VP1 is folded so that Lys-114 is in the beta E-beta F loop of the polypeptide chain at a considerable distance from Pro-240 and Trp-241 in the C-terminal region. However, around the fivefold axis of symmetry, the C terminus of VP1 in each protomer extends to the beta E-beta F loop of the adjacent VP1 in the next protomer. We therefore propose that the immunogenic site in ERAV is formed as a result of the close proximity of the Lys-114 residue in the beta E-beta F loop of one VP1 molecule and of the Pro-240/Thr-241 residues in the adjacent VP1 polypeptide chain. In terms of the overall architecture of the viral capsid structure, this site in ERAV most closely resembles the immunogenic site 1 of FMDV O(1).
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0022-1317
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
84
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2365-73
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:12917457-Amino Acid Sequence,
pubmed-meshheading:12917457-Animals,
pubmed-meshheading:12917457-Aphthovirus,
pubmed-meshheading:12917457-Binding Sites, Antibody,
pubmed-meshheading:12917457-Capsid,
pubmed-meshheading:12917457-Epitopes,
pubmed-meshheading:12917457-Genome, Viral,
pubmed-meshheading:12917457-Mice,
pubmed-meshheading:12917457-Mice, Inbred BALB C,
pubmed-meshheading:12917457-Models, Molecular,
pubmed-meshheading:12917457-Molecular Sequence Data,
pubmed-meshheading:12917457-Mutation,
pubmed-meshheading:12917457-Neutralization Tests,
pubmed-meshheading:12917457-Sequence Alignment
|
pubmed:year |
2003
|
pubmed:articleTitle |
Model of the equine rhinitis A virus capsid: identification of a major neutralizing immunogenic site.
|
pubmed:affiliation |
Max F. Perutz Laboratories, University Departments at the Vienna Biocenter, Department of Medical Biochemistry, Division of Biochemistry, University of Vienna, Dr Bohr Gasse 9/3, A-1030 Vienna, Austria.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|